Recent advances in MEN1 gene study for pituitary tumor pathogenesis

Area of Science:

• Endocrinology
• Genetics
• Oncology

Background:

• Multiple Endocrine Neoplasia type 1 (MEN1) is linked to approximately 2.7% of pituitary adenoma cases.
• Pituitary tumors in MEN1 patients, particularly prolactinomas, tend to be larger and more aggressive.
• The exact role of menin, the product of the MEN1 gene, remains unclear.

Purpose of the Study:

• To investigate the association between MEN1 and pituitary adenomas.
• To explore the characteristics of pituitary tumors in MEN1 patients.
• To review the genetic basis and pathogenic mechanisms of MEN1-related pituitary disorders.

Main Methods:

• Literature review of studies on MEN1 and pituitary adenomas.
• Analysis of clinical and genetic data from patients with MEN1 and pituitary tumors.
• Review of identified MEN1 gene mutations and their functional implications.

Main Results:

• Prolactinomas are the most common pituitary tumors in MEN1.
• MEN1-associated pituitary tumors exhibit increased size and aggressiveness compared to sporadic cases.
• Germline mutations in the MEN1 gene are the primary cause, though specific mutation hotspots and genotype-phenotype correlations are not well-defined.
• Somatic MEN1 gene mutations appear to have a limited role in sporadic pituitary adenoma development.

Conclusions:

• MEN1 significantly influences pituitary adenoma presentation, size, and aggressiveness.
• Further research is needed to elucidate the function of menin and establish precise genotype-phenotype correlations.
• Understanding MEN1's role is crucial for managing pituitary tumors in affected individuals.